Substituted quinolines for the treatment of cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7728000
APP PUB NO 20070105784A1
SERIAL NO

10580140

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

is a radical selected from H, a radical of formula (IIa), a radical of formula (IIb), the N-radical of 1,8-naphthalimide, the C4-radical of 2-phenylquinoline, and the C9-radical of acridine.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS28006 MADRID
UNIVERSITAT POLITECNICA DE CATALUNYA08034 BARCELONA
CRYSTAX PHARMACEUTICALS S L08028 BARCELONA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bofarull, Juan Aymami Barcelona, ES 2 1
Capella, Miquel Coll Madrid, ES 1 0
Muñoz, Isabel Navarro Barcelona, ES 2 1
Soldevila, Amadeo Llebaria Madrid, ES 2 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation